Quiero saber acerca de...

Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Proposed Rules withdrawn from warehouse for consumption, before EFFECTIVE DATE
OF FINAL RULE, these specific purposes are: country of origin marking;
determining the rate of duty and staging category applicable to originating textile and apparel products as set out in Section 2 Tariff Elimination of Annex 300B Textile and Apparel Goods under NAFTA; and determining the rate of duty and staging category applicable to an originating good as set out in Annex 302.2 Tariff Elimination under NAFTA. CBP will determine the country of origin for all non-preferential purposes for goods imported into the United States from Canada or Mexico and entered for consumption, or withdrawn from warehouse for consumption, on or after EFFECTIVE
DATE OF FINAL RULE, using the rules set forth in 102.1 through 102.18 and 102.20. The rules in this part regarding goods wholly obtained or produced in a country are intended to apply consistently for all such purposes. The rules in this part which determine when a good becomes a new and different article or a new or different article of commerce as a result of manufacturing processes in a given country are also intended to apply consistently for all purposes where this requirement exists for country of origin or product of determinations made by CBP for goods imported from Canada or Mexico. The rules in this part do not affect similar determinations made by other agencies, such as the Department of Commerces scope determinations in antidumping or countervailing duty proceedings see 19
CFR 351.225.

3. The general authority citation for part 177 is revised to read as follows:

Authority: 5 U.S.C. 301; 19 U.S.C. 66, 1202 General Note 3i, Harmonized Tariff Schedule of the United States, 1502, 1624, 1625, 2515.

4. Amend 177.22 by adding a sentence to the end of paragraph a to read as follows:

jbell on DSKJLSW7X2PROD with PROPOSALS

Definitions.

a For goods imported into the United States after processing in Canada or Mexico and entered for consumption, or withdrawn from warehouse for consumption, on or after EFFECTIVE
DATE OF FINAL RULE, substantial transformation will be determined using the rules set forth in 102.1 through 102.18 and 102.20.

Troy A. Miller, the Senior Official Performing the Duties of the
VerDate Sep<11>2014

16:39 Jul 02, 2021

Jkt 253001

Robert F. Altneu, Director, Regulations & Disclosure Law Division, Regulations & Rulings, Office of Trade, U.S. Customs and Border Protection.
Approved:
Timothy E. Skud, Deputy Assistant Secretary of the Treasury.
FR Doc. 202114265 Filed 7121; 11:15 am BILLING CODE 911114P

DEPARTMENT OF COMMERCE
Patent and Trademark Office 37 CFR Part 1
Docket No. PTOP20210006
RIN 0651AD53

Standard for Presentation of Nucleotide and Amino Acid Sequence Listings Using XML eXtensible Markup Language in Patent Applications To Implement WIPO
Standard ST.26; Incorporation by Reference United States Patent and Trademark Office, Department of Commerce.
ACTION: Notice of proposed rulemaking.
AGENCY:

The United States Patent and Trademark Office USPTO or Office is proposing to revise the rules of practice for submitting biological sequence data associated with disclosures of nucleotide and amino acid sequences in patent applications by incorporating by reference the provisions of Standard ST.26 into the USPTO rules. Other conforming changes to accommodate for proposed new rules of practice based on the new standard are also included.
These proposed amendments would apply to international and national applications filed on or after January 1, 2022. In addition to simplifying the process for applicants filing in multiple countries, a requirement to submit a single sequence listing in eXtensible Mark-up Language XML format will result in better preservation, accessibility, and sorting of the submitted sequence data for the public.
DATES: Comments must be received by September 7, 2021 to ensure consideration.
SUMMARY:

PART 177ADMINISTRATIVE
RULINGS

177.22

Commissioner, having reviewed and approved this document, is delegating the authority to electronically sign this document to Robert F. Altneu, who is the Director of the Regulations and Disclosure Law Division for CBP, for purposes of publication in the Federal Register.

PO 00000

Frm 00021

Fmt 4702

Sfmt 4702

35429

For reasons of Government efficiency, comments must be submitted through the Federal eRulemaking Portal at www.regulations.gov. To submit comments via www.regulations.gov, enter docket number PTOP20210006
on the homepage and click Search.
The site will provide a search results page listing all documents associated with this docket. Find a reference to this notice and click on the Comment Now! icon, complete the required fields, and enter or attach your comments. Attachments to electronic comments will be accepted in ADOBE
portable document format or MICROSOFT WORD format. Because comments will be made available for public inspection, information that the submitter does not desire to make public, such as an address or phone number, should not be included in the comments.
Visit the Federal eRulemaking Portal website www.regulations.gov for additional instructions on providing comments via the portal. If electronic submission of comments is not feasible due to lack of access to a computer and/
or the internet, please contact the USPTO using the contact information below for special instructions.
FOR FURTHER INFORMATION CONTACT:
Mary C. Till, Senior Legal Advisor, Office of Patent Legal Administration, Office of the Deputy Commissioner for Patents, by email at Mary.Till@
uspto.gov; or Ali Salimi, Senior Legal Advisor, Office of Patent Legal Administration, Office of the Deputy Commissioner for Patents, by email at Ali.Salimi@uspto.gov. Contact via telephone at 5712727704 for special instructions on submission of comments.
SUPPLEMENTARY INFORMATION:
ADDRESSES:

Table of Contents I. Background a. Summary of Changes b. Introduction c. Standard ST.26
d. Benefits e. WIPO Authoring and Validation Tool WIPO Sequence f. Applicability II. Discussion of Specific Rules III. Rulemaking Considerations
I. Background a. Summary of Changes Standard ST.26 is the new international standard developed by the World Intellectual Property Organization WIPO and member states and adopted by the same. Under Standard ST.26, patent applications that contain disclosures of nucleotides and/
or amino acid sequences must present
E:FRFM06JYP1.SGM

06JYP1